Cargando…
Irisin inhibits high glucose‐induced endothelial‐to‐mesenchymal transition and exerts a dose‐dependent bidirectional effect on diabetic cardiomyopathy
Emerging evidence indicates that irisin provides beneficial effects in diabetes. However, whether irisin influences the development of diabetic cardiomyopathy (DCM) remains unclear. Therefore, we investigated the potential role and mechanism of action of irisin in diabetes‐induced myocardial dysfunc...
Autores principales: | Liu, Xue, Mujahid, Haroon, Rong, Bing, Lu, Qing‐hua, Zhang, Wei, Li, Peng, Li, Na, Liang, Er‐shun, Wang, Qi, Tang, Dong‐qi, Li, Nai‐lin, Ji, Xiao‐ping, Chen, Yu‐guo, Zhao, Yu‐xia, Zhang, Ming‐xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783871/ https://www.ncbi.nlm.nih.gov/pubmed/29063670 http://dx.doi.org/10.1111/jcmm.13360 |
Ejemplares similares
-
Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
por: Xie, Yeqing, et al.
Publicado: (2018) -
Irisin Exerts Neuroprotective Effects on Cultured Neurons by Regulating Astrocytes
por: Wang, Kexin, et al.
Publicado: (2018) -
Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
por: Pan, Jian-an, et al.
Publicado: (2021) -
Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through microRNA126‐5p
por: Zhang, Yuzhu, et al.
Publicado: (2016) -
The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
por: Yano, Naohiro, et al.
Publicado: (2021)